Literature Collection

Magnifying Glass
Collection Insights

12K+

References

11K+

Articles

1600+

Grey Literature

4800+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
12771 Results
7081
Medically Unexplained Physical Symptoms: Why Counseling Psychologists Should Care About Them
Type: Journal Article
Authors: Lisa M. McAndrew, Myrna L. Friedlander, David R. Litke, Phillips L. Alison, Justin M. Kimber, Drew A. Helmer
Year: 2019
Publication Place: College Park
Topic(s):
Education & Workforce See topic collection
,
Medically Unexplained Symptoms See topic collection
7082
Medically unexplained symptoms and the problem of power in the primary care consultation: a qualitative study
Type: Journal Article
Authors: L. Wileman, C. May, C. A. Chew-Graham
Year: 2002
Publication Place: England
Abstract: BACKGROUND: Patients presenting in primary care frequently exhibit physical symptoms that may be unrelated to organic pathology. Such symptoms are commonly regarded as products of psychological or emotional problems, and their legitimacy as 'medical' matters is often called into question. OBJECTIVES: Our aim was to explore GPs' attitudes to the management of patients that present with medically unexplained symptoms in primary care. METHODS: Semi-structured interviews were conducted with 15 GPs in North-West England. Interviews were audio-taped and subsequently transcribed and analysed using a constant comparison technique. RESULTS: Subjects conceptualized patients presenting with medically unexplained symptoms as the presentation of psychological distress. They presented problems of control and authority in the consultation, and difficulties in managing this had a negative impact on the doctor-patient relationship. Such consultations were frustrating for the GP and potentially harmful to the patient. CONCLUSION: Patients with medically unexplained symptoms were seen to be presenting with inappropriate symptoms that were a manifestation of emotional or social distress. GPs felt ill-equipped to deal with the presentations and the frustrations they felt and may need help in actively and productively managing these patients.
Topic(s):
Medically Unexplained Symptoms See topic collection
7083
Medically unexplained symptoms in family medicine: defining a research agenda. Proceedings from WONCA 2007
Type: Journal Article
Authors: Olde Hartman, L. Hassink-Franke, C. Dowrick, S. Fortes, C. Lam, H. van der Horst, P. Lucassen, E. van Weel-Baumgarten
Year: 2008
Publication Place: England
Abstract: BACKGROUND: Medically unexplained symptoms (MUSs) are frequently presented in primary care. Unfortunately, knowledge of these patients and/or symptoms in primary care is still limited. Available research comes mainly from Europe and North America, while the perspectives of cultures such as Africa, Asia and South America are relatively unknown. To bring cultural perspectives together, a symposium and workshop on MUS in primary care was held at the WONCA World Conference 2007 in Singapore. OBJECTIVE: Main goals of this symposium and workshop-apart from presenting ongoing research and bringing together experts in MUS-were to detect knowledge gaps in MUS and to establish priorities in MUS research. This publication focuses on the proposed research agenda. METHODS: Using a nominal group technique, we generated research topics and set priorities. Research topics were grouped into research themes. RESULTS: Participants' (66 researchers and GPs from 29 nationalities) most important research topics were 'formulating a broadly accepted definition of MUS', 'finding a strategy to recognize MUS better and at an earlier stage', 'studying the value of self-management and empowerment in patients with MUS' and 'finding predictors to decide which strategy will best help the individual patient with MUS'. Priorities in research themes of MUS are as follows: (i) therapeutic options for patients with MUS and (ii) problems in consultations with these patients. CONCLUSIONS: More research on MUS in primary care is needed to improve the consultations with and management of these patients. Internationally primary care conferences are excellent for exchanging ideas and formulating central issues of research.
Topic(s):
Medically Unexplained Symptoms See topic collection
7084
Medically unexplained symptoms: perceptions of physicians in primary health care
Type: Journal Article
Authors: T. Woivalin, G. Krantz, T. Mantyranta, K. C. Ringsberg
Year: 2004
Publication Place: England
Abstract: BACKGROUND: Patients presenting with multiple symptoms represent a substantial part of a GP's total work load. At the same time, these patients account for the majority of the people on long-term sick-leave in Sweden today. OBJECTIVE: The aim of this study was to explore GPs' perceptions and ways of managing patients with medically unexplained symptoms (MUS). METHODS: Five focus group discussions were conducted with a total of 27 GPs. In the collection and analysis of data, a phenomenographic approach was used. RESULTS: The GPs described how they used four different approaches to manage patients with MUS: a biomedical, a psychological, an educational and a psychosocial approach. Different approaches were used, depending on the patient and the situation, and the GPs even switched approach when working with the same patient. CONCLUSIONS: In their work with patients with MUS, GPs need support and further training to improve the way the biomedical frame of reference is integrated with the humanistic perspective.
Topic(s):
Medically Unexplained Symptoms See topic collection
7085
Medically unexplained symptoms: the need for effective communication and an integrated care strategy
Type: Journal Article
Authors: K. J. Gormley
Year: 2014
Publication Place: England
Abstract: Much is already known about medically unexplained symptoms (MUS) in terms of incidence, presentation and current treatment. What needs to be urgently addressed is a strategy for dealing with patients and their conditions, particularly when they do not fall neatly into medical frameworks or pathologies where the syndrome can be easily explained. This article will consider the provision of health and social care support for patients with MUS within an interprofessional education context. The author will contend that a sensitive and valued service for this large client group is dependent upon services without professional boundaries and practitioners with a clinical interest that can work together and agree an appropriate way forward in terms of care, support and strategic service provision. The article will support the idea that clear guidelines through the National Institute for Health and Care Excellence can offer clear clinical direction for practitioners working in primary and secondary care settings to work together interprofessionally to ensure a seamless and sensitive service for people with this condition.
Topic(s):
Education & Workforce See topic collection
,
Medically Unexplained Symptoms See topic collection
7086
Medicare Accountable Care Organization Treatment of Serious Mental Illness: Associations Between Behavioral Health Integration Activities and Outcomes
Type: Journal Article
Authors: H. Newton, C. H. Colla, S. H. Busch, M. Tomaino, B. Hardy, M. F. Brunette, D. Agravat, E. Meara
Year: 2025
Abstract:

OBJECTIVE: Characterize the association between Medicare Accountable Care Organizations' (ACOs) behavioral health integration capability and quality and utilization among adults with serious mental illness (SMI). BACKGROUND: Controlled research supports the efficacy of integrating physical and mental health care for adults with SMI, yet little is known about the organizations integrating care and associations between integration capability and quality. METHODS: We surveyed Medicare ACOs (2017-2018 National Survey of ACOs, response rate 69%) and linked responses to 2016-2017 fee-for-service Medicare claims for beneficiaries with SMI. We examined the cross-sectional association between ACO-reported integration capability (tertiles of a 14-item index) and 7 patient-level quality and utilization outcomes. We fit generalized linear models for each outcome as a function of ACO integration capability, adjusting for ACO and beneficiary characteristics. RESULTS: Study sample included 274,928 beneficiary years (199,910 unique beneficiaries) attributed to 265 Medicare ACOs. ACOs with high behavioral health integration capability (top-tertile) served more dual-eligible beneficiaries (67.8%) than bottom-tertile (63.7%) and middle-tertile ACOs (63.3%). Most beneficiaries received follow-up 30 days after mental health hospitalization and chronic disease monitoring-exceeding national quality benchmarks-but beneficiaries receiving care from top-tertile (vs bottom-tertile) ACOs were modestly less likely to receive follow-up [-2.17 percentage points (pp), P < 0.05], diabetes monitoring (-2.19 pp, P < 0.05), and cardiovascular disease monitoring (-6.07 pp, P < 0.05). Integration capability was not correlated with utilization. CONCLUSIONS: ACOs serving adults with substantial physical and mental health needs were more likely to report comprehensive integration capability but were not yet meeting the primary care needs of many adults with SMI.

Topic(s):
Education & Workforce See topic collection
,
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
7087
Medicare Coverage Of Intensive Outpatient Programs Could Reduce State Behavioral Health Care Costs
Type: Report
Authors: Gretchen Bell, Andrew Spicer
Year: 2025
Publication Place: Washington, DC
Topic(s):
Financing & Sustainability See topic collection
,
Healthcare Policy See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7088
Medicare Coverage of Substance Use Disorder Care: A Landscape Review of Benefit Coverage, Service Gaps and a Path to Reform
Type: Report
Authors: Ellen Weber, Deborah Steinberg
Year: 2021
Publication Place: Washington, D.C.
Topic(s):
Grey Literature See topic collection
,
Healthcare Disparities See topic collection
,
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

Grey literature is comprised of materials that are not made available through traditional publishing avenues. Examples of grey literature in the Repository of the Academy for the Integration of Mental Health and Primary Care include: reports, dissertations, presentations, newsletters, and websites. This grey literature reference is included in the Repository in keeping with our mission to gather all sources of information on integration. Often the information from unpublished resources is limited and the risk of bias cannot be determined.

7089
Medicare Part D Opioid Prescribing Mapping Tool
Type: Web Resource
Authors: Centers for Medicare and Medicaid Services
Year: 2017
Topic(s):
Grey Literature See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7090
Medicare Payment for Behavioral Health Integration
Type: Journal Article
Authors: M. J. Press, R. Howe, M. Schoenbaum, S. Cavanaugh, A. Marshall, L. Baldwin, P. H. Conway
Year: 2017
Publication Place: United States
Topic(s):
Financing & Sustainability See topic collection
7091
Medicare's integration imperative: A policy analysis of care coordination barriers for older adults with co-occurring mental health and substance use disorders
Type: Journal Article
Authors: E. F. Kyei, M. N. Mumba
Year: 2025
Abstract:

BACKGROUND: Medicare serves 65 million Americans aged 65+, with 3.7% having co-occurring mental health and substance use disorders. Despite evidence supporting integrated care, fragmented Medicare policies result in higher readmissions and lower treatment completion rates for this vulnerable population. PURPOSE: To analyze Medicare policies using the Integration Continuum Framework and identify nursing practice and policy implications for older adults with dual diagnoses. METHODS: Systematic review of Medicare policy documents (2010-2023) analyzed through the Integration Continuum Framework across clinical, financial, and administrative dimensions. DISCUSSION: Medicare policies predominantly reflect minimal integration (Levels 1-2). Only 17.3% of beneficiaries with co-occurring disorders receive coordinated care, requiring visits to 3.7 providers across 2.8 facilities compared to 1.9 providers at 1.6 facilities for single diagnoses. The Collaborative Care Model achieves Level 3 integration but excludes substance use disorders, limiting comprehensive care. CONCLUSION: Medicare's fragmented approach creates significant coordination challenges. Nurses are uniquely positioned to bridge these gaps through screening protocols, care navigation, and leadership initiatives. Policy reforms including expanding the Collaborative Care Model to include substance use disorders, eliminating same-day billing restrictions, and streamlining documentation represent pathways toward comprehensive Level 4-5 integration, ultimately improving outcomes for older adults with dual diagnoses.

Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Education & Workforce See topic collection
7092
Medication and Counseling Treatment
Type: Web Resource
Authors: Substance Abuse and Mental Health Services Administration
Year: 2015
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7093
Medication assisted therapy and recovery homes
Type: Journal Article
Authors: Leonard A. Jason, John M. Majer, Ted J. Bobak, Jack O'Brien
Year: 2022
Topic(s):
Opioids & Substance Use See topic collection
Reference Links:       
7094
Medication assisted treatment (MAT): A dialogue with a multidisciplinary treatment team and their patients
Type: Journal Article
Authors: Lori Holleran Steiker, Kim Comstock, Steve Arechiga, Jade Mena, Melissa Hutchins-Jackson, Katrina Kelly
Year: 2013
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
7095
Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder
Type: Journal Article
Authors: C. Wilder, D. Lewis, T. Winhusen
Year: 2015
Publication Place: Ireland
Abstract: BACKGROUND: Increasing use of opioids has led to an increase in the number of pregnant and postpartum women in medication assisted treatment (MAT) for opioid use disorder. METHODS: We (1) conducted a systematic review of published literature on MAT discontinuation (methadone and buprenorphine) in pregnant and postpartum women and (2) determined methadone discontinuation rates in a retrospective cohort (2006-2013) of pregnant and postpartum women in a university affiliated methadone clinic. RESULTS: We found limited generalizable literature reports of discontinuation rates, with a range of prenatal discontinuation rates from 0 to 33% and rates which spanned various prenatal and postnatal periods from 26 to 64%. In our cohort of 229 women, 251 pregnancies were reported, with a prenatal methadone discontinuation rate of 11.0%. Based on a Cox proportional hazards model controlling for age, pregnancy outcome, and duration of treatment prior to delivery, the probability of methadone discontinuation at or before 6 months postpartum was 56.0%. Duration of methadone treatment prior to delivery was inversely associated with risk for postpartum discontinuation of treatment (HR = 0.98, 95% CI (0.96, 0.99)). CONCLUSIONS: We conclude that the postpartum period is a time of increased risk for discontinuation of MAT. More accurate assessment of rates of pre- and postpartum MAT discontinuation, as well as further investigation of factors affecting these rates, is warranted. Development and testing of interventions to encourage early prenatal enrollment in MAT and improve postnatal retention in MAT would benefit pregnant women and new mothers with opioid use disorder.
Topic(s):
Opioids & Substance Use See topic collection
7096
Medication Assisted Treatment for Opioid Addiction
Type: Web Resource
Authors: Mark Fisher
Year: 2015
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7097
Medication Assisted Treatment for Opioid Use Disorders: Overview of the Evidence
Type: Report
Authors: University of Washington Alcohol and Drug Abuse Institute
Year: 2015
Publication Place: http://www.refworks.com/refworks2/default.aspx?r=references|MainLayout::init#
Topic(s):
Opioids & Substance Use See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7098
Medication Assisted Treatment for Opioid Use Disorders. Final rule
Type: Journal Article
Authors: Department of Health and Human Services Substance Abuse and Mental Health Services Administration
Year: 2016
Publication Place: United States
Abstract: This final rule increases access to medication-assisted treatment (MAT) with buprenorphine and the combination buprenorphine/naloxone (hereinafter referred to as buprenorphine) in the office-based setting as authorized under the United States Code. Section 303(g)(2) of the Controlled Substances Act (CSA) allows individual practitioners to dispense or prescribe Schedule III, IV, or V controlled substances that have been approved by the Food and Drug Administration (FDA). Section 303(g)(2)(B)(iii) of the CSA allows qualified practitioners who file an initial notification of intent (NOI) to treat a maximum of 30 patients at a time. After 1 year, the practitioner may file a second NOI indicating his/her intent to treat up to 100 patients at a time. This final rule will expand access to MAT by allowing eligible practitioners to request approval to treat up to 275 patients under section 303(g)(2) of the CSA. The final rule also includes requirements to ensure that patients receive the full array of services that comprise evidence-based MAT and minimize the risk that the medications provided for treatment are misused or diverted.
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
7099
Medication Assisted Treatment for Substance Use Disorders within a National Community Health Center Research Network
Type: Journal Article
Authors: T. Rieckmann, J. Muench, M. A. McBurnie, M. C. Leo, P. Crawford, D. Ford II, J. Stubbs, C. O'Cleirigh, K. H. Mayer, K. Fiscella, N. Wright, M. Doe-Simkins, M. Cuddeback, E. Salisbury-Afshar, C. Nelson
Year: 2016
Abstract: BACKGROUND: The Affordable Care Act increases access to treatment services for people who suffer from substance use disorders (SUDs), including alcohol use disorders (AUDs) and opioid use disorders (OUDs). This increased access to treatment has broad implications for delivering health services and creates a dramatic need for transformation in clinical care, service lines, and collaborative care models. Medication assisted treatments (MAT) are effective for helping SUD patients reach better outcomes. This manuscript uses electronic health record (EHR) data to examine the prevalence of EHR-documented SUD, patient characteristics, and patterns of MAT prescribing and screening for patients within the Community Health Applied Research Network (CHARN), a national network of 17 community health centers that facilitates patient-centered outcomes research among underserved populations. METHODS: Hierarchical generalized linear models examined patient characteristics, SUD occurrence rates, MAT prescription, and HIV and Hepatitis Virus C screening for patients with AUDs or OUDs. RESULTS: Among 572,582 CHARN adult patients, 16,947 (3.0%) had a documented AUD diagnosis and 6,080 (1.1%) an OUD diagnosis. Alcohol MAT prescriptions were documented for 547 AUD patients (3.2%) and opioid MAT for 1,764 OUD patients (29.0%). Among OUD patients, opioid MAT was significantly associated with HIV screening (OR = 1.31, p<.001) in OUD patients as was alcohol MAT among AUD patients (OR = 1.30, p = .013). CONCLUSIONS: Our findings suggest that effective opioid and alcohol MAT may be substantially under-prescribed among safety-net patients identified as having OUD or AUD.
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
HIT & Telehealth See topic collection
,
Healthcare Policy See topic collection
7100
Medication assisted treatment in community health centers: Patient characteristics and treatment needs
Type: Journal Article
Authors: Nicholas Gideonse
Year: 2012
Topic(s):
Opioids & Substance Use See topic collection